Alicja Gruszka

1.3k total citations
36 papers, 945 citations indexed

About

Alicja Gruszka is a scholar working on Genetics, Hematology and Molecular Biology. According to data from OpenAlex, Alicja Gruszka has authored 36 papers receiving a total of 945 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Genetics, 17 papers in Hematology and 13 papers in Molecular Biology. Recurrent topics in Alicja Gruszka's work include Chronic Lymphocytic Leukemia Research (15 papers), Acute Myeloid Leukemia Research (12 papers) and Lymphoma Diagnosis and Treatment (11 papers). Alicja Gruszka is often cited by papers focused on Chronic Lymphocytic Leukemia Research (15 papers), Acute Myeloid Leukemia Research (12 papers) and Lymphoma Diagnosis and Treatment (11 papers). Alicja Gruszka collaborates with scholars based in Italy, United Kingdom and Australia. Alicja Gruszka's co-authors include Estella Matutes, Daniel Catovsky, Myriam Alcalay, Debora Valli, Rifat Hamoudi, Andrew Wotherspoon, Daniel Catovsky, Manal O. Elnenaei, Nilima Parry‐Jones and G. John Swansbury and has published in prestigious journals such as Journal of Clinical Investigation, Blood and Scientific Reports.

In The Last Decade

Alicja Gruszka

36 papers receiving 924 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Alicja Gruszka Italy 20 395 380 378 274 259 36 945
Daniel Heintel Austria 13 442 1.1× 289 0.8× 346 0.9× 322 1.2× 205 0.8× 30 846
Xinyan Lu United States 20 280 0.7× 271 0.7× 313 0.8× 375 1.4× 292 1.1× 58 969
Barbara MacGregor‐Cortelli United States 10 605 1.5× 500 1.3× 248 0.7× 234 0.9× 424 1.6× 12 1.1k
Mirosław Majewski Poland 16 522 1.3× 353 0.9× 279 0.7× 308 1.1× 456 1.8× 28 1.4k
Linda Wellik United States 20 724 1.8× 404 1.1× 306 0.8× 471 1.7× 444 1.7× 34 1.3k
Maher Albitar United States 14 321 0.8× 197 0.5× 287 0.8× 305 1.1× 213 0.8× 48 783
Amanda Copeland United States 15 536 1.4× 558 1.5× 315 0.8× 116 0.4× 623 2.4× 36 1.2k
Johannes Coy Germany 10 332 0.8× 356 0.9× 490 1.3× 78 0.3× 221 0.9× 12 912
Kimberly Hayes United States 19 428 1.1× 394 1.0× 753 2.0× 833 3.0× 337 1.3× 38 1.5k
Daniela Gottardi Italy 11 353 0.9× 379 1.0× 605 1.6× 120 0.4× 193 0.7× 19 1.0k

Countries citing papers authored by Alicja Gruszka

Since Specialization
Citations

This map shows the geographic impact of Alicja Gruszka's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alicja Gruszka with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alicja Gruszka more than expected).

Fields of papers citing papers by Alicja Gruszka

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alicja Gruszka. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alicja Gruszka. The network helps show where Alicja Gruszka may publish in the future.

Co-authorship network of co-authors of Alicja Gruszka

This figure shows the co-authorship network connecting the top 25 collaborators of Alicja Gruszka. A scholar is included among the top collaborators of Alicja Gruszka based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alicja Gruszka. Alicja Gruszka is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Conti, Giulia De, et al.. (2020). A Novel Platform to Test In Vivo Single Gene Dependencies in t(8,21) and t(15,17) AML Confirms Zeb2 as Leukemia Target. Cancers. 12(12). 3768–3768. 4 indexed citations
2.
Gruszka, Alicja, Debora Valli, Gianluca Deflorian, et al.. (2020). HDAC8: A Promising Therapeutic Target for Acute Myeloid Leukemia. Frontiers in Cell and Developmental Biology. 8. 844–844. 40 indexed citations
3.
Gruszka, Alicja, Debora Valli, & Myriam Alcalay. (2019). Wnt Signalling in Acute Myeloid Leukaemia. Cells. 8(11). 1403–1403. 63 indexed citations
4.
5.
Długosz‐Danecka, Monika, Alicja Gruszka, Sebastian Szmit, et al.. (2018). Primary Cardioprotection Reduces Mortality in Lymphoma Patients with Increased Risk of Anthracycline Cardiotoxicity, Treated by R-CHOP Regimen. Chemotherapy. 63(4). 238–245. 17 indexed citations
6.
Ronchini, Chiara, Laura Riva, Lucilla Luzi, et al.. (2016). PML-RARA-associated cooperating mutations belong to a transcriptional network that is deregulated in myeloid leukemias. Leukemia. 31(9). 1975–1986. 6 indexed citations
7.
Termanini, Alberto, Nicoletta Rizzi, Massimiliano Mazza, et al.. (2016). AML1/ETO accelerates cell migration and impairs cell-to-cell adhesion and homing of hematopoietic stem/progenitor cells. Scientific Reports. 6(1). 34957–34957. 17 indexed citations
8.
Gruszka, Alicja, Cristina Rabascio, Laura Cannella, et al.. (2015). Molecular investigation of coexistent chronic myeloid leukaemia and peripheral T-cell lymphoma – a case report. Scientific Reports. 5(1). 14829–14829. 2 indexed citations
9.
Santoro, Fabio, Isabella Pallavicini, Alicja Gruszka, et al.. (2011). The self-association coiled-coil domain of PML is sufficient for the oncogenic conversion of the retinoic acid receptor (RAR) alpha. Leukemia. 25(5). 814–820. 29 indexed citations
10.
Licciulli, Silvia, et al.. (2009). Pirin downregulation is a feature of AML and leads to impairment of terminal myeloid differentiation. Leukemia. 24(2). 429–437. 19 indexed citations
11.
Andersen, Claus L., Alicja Gruszka, Shayne Atkinson, et al.. (2005). Recurrent genomic imbalances in B-cell splenic marginal-zone lymphoma revealed by comparative genomic hybridization. Cancer Genetics and Cytogenetics. 156(2). 122–128. 16 indexed citations
12.
Trøen, Gunhild, Vigdis Nygaard, Tor‐Kristian Jenssen, et al.. (2004). Constitutive Expression of the AP-1 Transcription Factors c-jun, junD, junB, and c-fos and the Marginal Zone B-Cell Transcription Factor Notch2 in Splenic Marginal Zone Lymphoma. Journal of Molecular Diagnostics. 6(4). 297–307. 42 indexed citations
13.
Andersen, Claus L., Alicja Gruszka, Mette Østergaard, et al.. (2004). A narrow deletion of 7q is common to HCL, and SMZL, but not CLL. European Journal Of Haematology. 72(6). 390–402. 23 indexed citations
14.
Parry‐Jones, Nilima, Estella Matutes, Alicja Gruszka, et al.. (2003). Prognostic features of splenic lymphoma with villous lymphocytes: a report on 129 patients. British Journal of Haematology. 120(5). 759–764. 91 indexed citations
15.
Alvares, Caroline, Estella Matutes, Marie Scully, et al.. (2003). Isolated Bone Marrow Involvement in Diffuse Large B Cell Lymphoma: A Report of Three Cases with Review of Morphological, Immunophenotypic and Cytogenetic Findings. Leukemia & lymphoma. 45(4). 769–775. 34 indexed citations
16.
Gruszka, Alicja, Rifat Hamoudi, Lucy R. Osborne, Estella Matutes, & Daniel Catovsky. (2002). Deletion mapping on the long arm of chromosome 7 in splenic lymphoma with villous lymphocytes. Genes Chromosomes and Cancer. 36(1). 57–69. 26 indexed citations
17.
Elnenaei, Manal O., Rifat Hamoudi, John Swansbury, et al.. (2002). Delineation of the minimal region of loss at 13q14 in multiple myeloma. Genes Chromosomes and Cancer. 36(1). 99–106. 51 indexed citations
18.
Gruszka, Alicja, Rifat Hamoudi, Estella Matutes, Esperanza Tuset, & Daniel Catovsky. (2001). p53 abnormalities in splenic lymphoma with villous lymphocytes. Blood. 97(11). 3552–3558. 62 indexed citations
19.
Gruszka, Alicja, et al.. (1999). The incidence of trisomy 3 in splenic lymphoma with villous lymphocytes: a study by FISH. British Journal of Haematology. 104(3). 600–604. 28 indexed citations
20.
Zawilińska, Barbara, et al.. (1996). [The frequency of cytomegalovirus infection (CMV) in patients immunocompromised patients with malignant and nonmalignant blood disorders].. PubMed. 27(1). 65–71. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Daniel Heintel Breakdown of academic impact, for papers by Xinyan Lu Breakdown of academic impact, for papers by Barbara MacGregor‐Cortelli Breakdown of academic impact, for papers by Mirosław Majewski Breakdown of academic impact, for papers by Linda Wellik Breakdown of academic impact, for papers by Maher Albitar Breakdown of academic impact, for papers by Amanda Copeland Breakdown of academic impact, for papers by Johannes Coy Breakdown of academic impact, for papers by Kimberly Hayes Breakdown of academic impact, for papers by Daniela Gottardi
Rankless by CCL
2026